Archives: 2026-06-16

Calcium and vitamin D supplements offer little to no meaningful benefit on fracture and fall prevention

Recommendations for calcium and vitamin D supplementation should be re-evaluated, suggest researchers Calcium, vitamin D, or combined supplements offer little to no clinically meaningful benefit on fracture and fall prevention in most older people, finds an in-depth review of the latest evidence published by The BMJ . Almost a third of people aged 65 and older fall each year,

Read More


Review provides latest evidence on low back pain assessment and treatment

Low back pain affects around 619 million people worldwide, but a new review suggests many are receiving unnecessary scans and ineffectual treatments. Researchers compiled latest evidence from hundreds of studies to provide clinicians with an up-to-date guide to assist with assessment and management, with ​“Low Back Pain: A Review” published in JAMA. Professor James McAuley and Dr Aidan Cashin

Read More


Risk thresholds for kidney disease confirmed by more precise measurements

The kidney function thresholds currently used to diagnose chronic kidney disease reflect an actual increase in the risk of serious disease, according to a study from Karolinska Institutet and Leiden University Medical Center published in the journal JAMA. The researchers also show that risk assessment becomes more accurate when two common blood tests, creatinine and

Read More


RAS(ON) Inhibitor Doubles Median Overall Survival in Results of Phase 3 Trial for Patients with Metastatic Pancreatic Cancer

At the ASCO annual meeting, Dana-Farber’s Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously treated metastatic pancreatic cancer, regardless of RAS mutation status, taking daraxonrasib, an investigational oral RAS(ON) multi-selective inhibitor, compared with chemotherapy. A shift in the way people

Read More